Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control

NCT05977751 is registered in ClinicalTrials.gov with Femasys Inc. as lead sponsor.

NCT NCT05977751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05977751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control
Lead sponsor
Femasys Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2023
Completion date
June 30, 2031
Enrollment
573 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

contraception